SAGE Stock Price, Forecast & News (SAGE Therapeutics) 20 Wall Street analysts have issued twelve-month price objectives for SAGE Therapeutics' shares. Their forecasts range from $28.00 to $263.00. On average, they expect SAGE Therapeutics' stock price to reach $100.05 in the next twelve months. This suggests a possible upside of 285.1% from the stock's current price.

Sage Therapeutics (SAGE) has the following price history information. Looking back at SAGE historical stock prices for the last five trading days, on March 20, 2020, SAGE opened at $28.50, traded as high as $30.31 and as low as $26.44, and closed at $26.60. Trading volume was a total of 1.64M shares. SAGE Stock News - Fidelity Apr 03, 2020 · Sage Therapeutics, Inc. (SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that on April 1, 2020, the Compensation Committee of Sage s Board of Directors granted non-qualified stock options to purchase an aggregate of 540 shares of its common stock, and … SAGE - Stock quote for SAGE THERAPEUTICS, INC. - MSN Money View the latest SAGE stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of SAGE THERAPEUTICS, INC.. Check SAGE stock rating before trading SAGE Therapeutics Inc

Sage Group plc Share Price (SGE) Ordinary 1 4/77p | SGE

Sage Therapeutics, Inc. (SAGE) Stock Price, Quote, History ... Find the latest Sage Therapeutics, Inc. (SAGE) stock quote, history, news and other vital information to help you with your stock trading and investing. SGE:London Stock Quote - Sage Group PLC/The - Bloomberg ... Stock analysis for Sage Group PLC/The (SGE:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sage Therapeutics, Inc. Common Stock (SAGE) Stock Quotes ... Mar 27, 2020 · Sage Therapeutics, Inc. Common Stock (SAGE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

See SAGE Therapeutics price target based on 14 analysts offering 12 month price targets for SAGE Therapeutics in the last 3 months. The average price target 

SAGE Stock News - Fidelity Apr 03, 2020 · Sage Therapeutics, Inc. (SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that on April 1, 2020, the Compensation Committee of Sage s Board of Directors granted non-qualified stock options to purchase an aggregate of 540 shares of its common stock, and … SAGE - Stock quote for SAGE THERAPEUTICS, INC. - MSN Money View the latest SAGE stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of SAGE THERAPEUTICS, INC.. Check SAGE stock rating before trading SAGE Therapeutics Inc

Sage Group Share Price. SGE - Stock Quote, Charts, Trade ...

Discover historical prices for SAGE stock on Yahoo Finance. View daily, weekly or monthly format back to when Sage Therapeutics, Inc. stock was issued. Find the latest Sage Therapeutics, Inc. (SAGE) stock quote, history, news and other vital information to help you with your stock trading and investing. Records 1 - 18 of 22 Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2019, EDGAR®Online, a division of Donnelley 

Sage Therapeutics, Inc. (SAGE) Stock Analysis & News ...

Sage Therapeutics, Inc. Common Stock (SAGE) Historical ... Find the latest historical data for Sage Therapeutics, Inc. Common Stock (SAGE) at Nasdaq.com. Sage Therapeutics, Inc. (SAGE) Stock Price, Quote, History ...

Using the Stock History Inquiry feature of Sage Enterprise Management (X3) is a another supplier, lower price alternative product now in the marketplace, etc). SAGE Sage Therapeutics, Inc. daily Stock Chart Feb-25-20 12:03PM, The Sage Therapeutics (NASDAQ:SAGE) Share Price Is Up -56% And Shareholders Are  3 Oct 2019 Stocks quotes in this article: SAGE. During the In this daily bar chart of SAGE, below, we can see a downtrend from July. Prices have fallen  Chart not available Sage Therapeutics Announces Development Plan For Zuranolone Following Meeting With The FDA COMMON STOCK AT A PUBLIC OFFERING PRICE OF $164.00 PER SHARE Source text for Eikon: Further company  Sage is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Contents. 1 History.